Filing Flows › Comparisons › ENTA vs WVE
Enanta Pharmaceuticals vs Wave Life Sciences: ENTA and WVE compared
Enanta Pharmaceuticals is the larger company: $14.4M of revenue in its latest quarter (Q3 FY26) against $13.2M for Wave Life Sciences (Q3 2026). Wave Life Sciences is growing faster (+73% against -22% a year earlier). Enanta Pharmaceuticals is more profitable, with an operating margin of -120.0% against -502.0%.
Where the money goes: ENTA and WVE
Enanta Pharmaceuticals (ENTA) · Q3 FY26
Enanta Pharmaceuticals, Q3 FY26: revenue $14.4M (-22% year over year), operating margin -120.0%, net loss $19.5M, operating cash flow −$10.0M. The chart follows the revenue to costs, profit and cash.
Wave Life Sciences (WVE) · Q3 2026
Wave Life Sciences, Q3 2026: revenue $13.2M (+73% year over year), operating margin -502.0%, net loss $61.9M, operating cash flow −$60.1M. The chart follows the revenue to costs, profit and cash.
| Enanta Pharmaceuticals (ENTA) | Wave Life Sciences (WVE) | |
|---|---|---|
| Latest quarter | Q3 FY26 | Q3 2026 |
| Revenue | $14.4M | $13.2M |
| Revenue growth, Y/Y | -22% | +73% |
| Operating margin | -120.0% | -502.0% |
| Net earnings | −$19.5M | −$61.9M |
| Net margin | -135.8% | -470.5% |
| Operating cash flow | −$10.0M | −$60.1M |
Questions
Which is bigger, Enanta Pharmaceuticals or Wave Life Sciences?
Enanta Pharmaceuticals is the larger company: $14.4M of revenue in its latest quarter (Q3 FY26) against $13.2M for Wave Life Sciences (Q3 2026).
Is Enanta Pharmaceuticals or Wave Life Sciences growing faster?
Wave Life Sciences is growing faster (+73% against -22% a year earlier).
Which is more profitable, Enanta Pharmaceuticals or Wave Life Sciences?
Enanta Pharmaceuticals is more profitable, with an operating margin of -120.0% against -502.0%.
More: Enanta Pharmaceuticals earnings · how Enanta Pharmaceuticals makes money · Wave Life Sciences earnings · how Wave Life Sciences makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Aug 12, 2026; 10-Q filed Oct 27, 2026). Fiscal quarters can end on different dates. Not investment advice.